355 filings
Page 4 of 18
8-K
1irad7r6gp
22 Jun 21
Departure of Directors or Certain Officers
5:15pm
8-K
geq94yih k80m421
11 May 21
VolitionRx Limited Announces First Quarter 2021 Financial Results and Business Update
4:12pm
8-K
ioj5v
29 Mar 21
VolitionRx Limited Appoints Two New Directors
4:16pm
8-K
6hirefw09nl
22 Mar 21
VolitionRx Limited Announces Full Fiscal Year 2020 Financial Results and Business Update
4:18pm
8-K
0kkgxq403f43k6
12 Feb 21
VolitionRx Limited Announces Pricing of $20 Million Underwritten Public Offering of Common Stock
4:39pm
424B5
ja84o0o
11 Feb 21
Prospectus supplement for primary offering
4:43pm
424B5
fs5trs4ff01oko9o vt
9 Feb 21
Prospectus supplement for primary offering
5:01pm
8-K
qfyka52flra09v ld
9 Feb 21
Results of Operations and Financial Condition
4:24pm
8-K
0l6td kek5y3ej
2 Feb 21
VolitionRx Provides a Business Update and Appoints Key Officers to Drive Commercialization Efforts
4:05pm
8-K
6vh35xq5h794x5ylcto
15 Jan 21
Entry into a Material Definitive Agreement
4:27pm
8-K
r1ha26ni3a s5vfy
3 Dec 20
VolitionRx Limited Appoints Dr. Tom Butera DVM to Board of Directors
4:17pm
424B5
m6rczph8
12 Nov 20
Prospectus supplement for primary offering
5:16pm
8-K
ctenk
12 Nov 20
VolitionRx Limited Announces Third Quarter 2020 Financial Results and Business Update
4:11pm
8-K
my6r63u
13 Aug 20
VolitionRx Limited Announces Second Quarter 2020 Financial Results and Business Update
4:17pm